Hospira Vinorelbine Tartrate for Injection 50 mg/5 mL vial

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

vinorelbine tartrate, Quantity: 13.85 mg/mL

제공처:

Hospira Australia Pty Ltd

INN (International Name):

Vinorelbine tartrate

약제 형태:

Injection

구성:

Excipient Ingredients: water for injections

관리 경로:

Intravenous

패키지 단위:

1 x 5 mL vial

수업:

Medicine Listed (Export Only)

처방전 유형:

Not scheduled. Not considered by committee

치료 징후:

Vinorelbine tartrate is indicated in the treatment of advanced non-small cell lung cancer (NSCLC), as a single agent or in combination. Vinorelbine tartrate is also indicated for the treatment of patients with metastatic breast cancer who have failed standard first-line chemotherapy for metastatic disease. In addition, vinorelbine tartrate is indicated for the treatment of patients with metastatic breast cancer who have relapsed within 6 months of anthracycline-based adjuvant therapy.

제품 요약:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2008-05-05